Professor Athena Poppas shared his insights on the Late Breaking Clinical Trial sessions:
- Effect Of Edetate Disodium Based Chelation Infusions On Cardiovascular Events In Post-MI Patients With Diabetes: The TACT2 Trial
- Percutaneous Transvalvular Micro-axial Flow Pump In Infarct Related Cardiogenic Shock: Results Of The Danger-shock Trial
- A Selective Aldose Reductase Inhibitor (at-001) For The Treatment Of Diabetic Cardiomyopathy: Primary Results Of The Phase 3 Randomized Controlled Arise-hf Study
Video: https://medicaldigest.org/scientific-contents/interview:late-breaking-clinical-trial-acc
